ERBB2 and breast neoplasm: Lastly, elevated IFNγ levels were detected using a mAb-based tracer targeting IFNγ (89Zr-anti-IFNγ) in neu+ mouse breast tumours following treatment with HER2/neu DNA vaccines [62].